Vestmark Advisory Solutions, Inc. Global Blood Therapeutics, Inc. Transaction History

Vestmark Advisory Solutions, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$22.3 - $37.39 $110,942 - $186,015	4,975 Added 39.27%	17,644 $564,000
Q1 2022 Apr 27, 2022	BUY	$25.68 - $35.59 $99,946 - $138,516	3,892 Added 44.34%	12,669 $439,000
Q4 2021 Jan 31, 2022	BUY	$24.9 - $40.26 $218,547 - $353,362	8,777 New	8,777 $257,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.